Arkolith/Insider Trading/INO/Form 4

Weiner David B.

DirectorINOVIO PHARMACEUTICALS, INC. (INO) · full profile →Form 4 · filed May 17, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$18K
Net Open-Market Flow
-$18K
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 16, 2022Sell(S)9K$1.95$18K893K
May 13, 2022Option exercise(M)18K——902K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 16, 2022Grant(A)28K—$028K
May 16, 2022Grant(A)19K—$019K
May 13, 2022Option exercise(M)18K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001055726-22-000041) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML